Neumora Therapeutics, Inc. Soared
Thu, Oct 23, 2025 at 07:32 PM
Neumora Therapeutics, Inc. (NMRA:NASDAQ) soared at $2.31, a gain of 35.1%. On Thu, Oct 23, 2025, NMRA:NASDAQ touched a New 2-Week High of $2.31. The stock got featured on our News Catalysts scanner on Wed, Oct 01, 2025 at 09:00 AM in the 'MISCELLANEOUS' category. From Thu, Oct 09, 2025, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Fri, Jul 25, 2025 at $2.85 with a volume of 4M+.
About Neumora Therapeutics, Inc. (NMRA:NASDAQ)
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases.
Top 10 Gainers:
- Scienture Holdings, Inc. (SCNX:NASDAQ), 354.94%
- MultiSensor AI Holdings, Inc. (MSAI:NASDAQ), 101.73%
- Ventyx Biosciences, Inc. (VTYX:NASDAQ), 70.98%
- Hong Kong Pharma Digital Technology Holdings Limited (HKPD:NASDAQ), 47.41%
- Kuke Music Holding Limited (KUKE:NYSE), 39.18%
- reAlpha Tech Corp. (AIRE:NASDAQ), 38.19%
- Brera Holdings PLC (SLMT:NASDAQ), 36.65%
- Neumora Therapeutics, Inc. (NMRA:NASDAQ), 35.09%
- Better Home & Finance Holding Company (BETR:NASDAQ), 30.55%
- INNEOVA Holdings Limited (INEO:NASDAQ), 30.37%